MFOHome About Commentary Discussions Funds The Best Resources Support Us!

Howdy, Stranger!

It looks like you're new here. If you want to get involved, click one of these buttons!

Sign In Register

Categories

Here's a statement of the obvious: The opinions expressed here are those of the participants, not those of the Mutual Fund Observer. We cannot vouch for the accuracy or appropriateness of any of it, though we do encourage civility and good humor.

    Support MFO

  • Donate through PayPal

Bye-Bye, Biotech Funds? Not So Fast. It Could Be Time For Another Look

TedTed
in The Bullpen
FYI: It has been a difficult few years for funds specializing in biotech stocks, and investors are pulling money from the sector fast.

More than $11 billion has flowed out of health-care/biotechnology funds so far this year, according to Lipper data from Refinitiv. That is worse than 2018, when just $430 million had flowed out by the end of September, and the year before, when $3.5 billion left.
Regards,
Ted
https://www.barrons.com/articles/biotech-funds-have-been-whipsawed-but-could-offer-value-51569635541?mod=djem_b_Weekly Feed for Barrons Magazine
Sign In or Register to comment.